These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25575980)

  • 21. HIV Protease Inhibitors Sensitize Human Head and Neck Squamous Carcinoma Cells to Radiation by Activating Endoplasmic Reticulum Stress.
    Liu R; Zhang L; Yang J; Zhang X; Mikkelsen R; Song S; Zhou H
    PLoS One; 2015; 10(5):e0125928. PubMed ID: 25933118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.
    Chan LP; Chou TH; Ding HY; Chen PR; Chiang FY; Kuo PL; Liang CH
    Biochim Biophys Acta; 2012 Jul; 1820(7):1081-91. PubMed ID: 22554915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells.
    Möckelmann N; Rieckmann T; Busch CJ; Becker B; Gleißner L; Hoffer K; Omniczynski M; Steinmeister L; Laban S; Grénman R; Petersen C; Rothkamm K; Dikomey E; Knecht R; Kriegs M
    Oncotarget; 2016 Apr; 7(17):23542-51. PubMed ID: 27015558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual "mAb" HER family blockade in head and neck cancer human cell lines combined with photon therapy.
    Guy JB; Méry B; Ollier E; Espenel S; Vallard A; Wozny AS; Simonet S; Lauret A; Battiston-Montagne P; Ardail D; Alphonse G; Rancoule C; Rodriguez-Lafrasse C; Magné N
    Sci Rep; 2017 Sep; 7(1):12207. PubMed ID: 28939847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines.
    Schnoell J; Sparr C; Al-Gboore S; Haas M; Brkic FF; Kadletz-Wanke L; Heiduschka G; Jank BJ
    Invest New Drugs; 2023 Dec; 41(6):842-850. PubMed ID: 37934325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
    Zumsteg ZS; Morse N; Krigsfeld G; Gupta G; Higginson DS; Lee NY; Morris L; Ganly I; Shiao SL; Powell SN; Chung CH; Scaltriti M; Baselga J
    Clin Cancer Res; 2016 Apr; 22(8):2009-19. PubMed ID: 26589432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma.
    Li P; Bian XY; Chen Q; Yao XF; Wang XD; Zhang WC; Tao YJ; Jin R; Zhang L
    PLoS One; 2017; 12(5):e0177484. PubMed ID: 28494008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suberoylanilide hydroxamic acid inhibits growth of head and neck cancer cell lines by reactivation of tumor suppressor microRNAs.
    Datta J; Islam M; Dutta S; Roy S; Pan Q; Teknos TN
    Oral Oncol; 2016 May; 56():32-9. PubMed ID: 27086484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor treating fields as novel combination partner in the multimodal treatment of head and neck cancer.
    Regnery S; Franke H; Held T; Trinh T; Naveh A; Abraham Y; Hörner-Rieber J; Hess J; Huber PE; Debus J; Lopez Perez R; Adeberg S
    Head Neck; 2023 Apr; 45(4):838-848. PubMed ID: 36872620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of salinomycin and radiation effectively eliminates head and neck squamous cell carcinoma cells in vitro.
    Gehrke T; Hackenberg S; Polat B; Wohlleben G; Hagen R; Kleinsasser N; Scherzad A
    Oncol Rep; 2018 Apr; 39(4):1991-1998. PubMed ID: 29436675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.
    Pickhard AC; Margraf J; Knopf A; Stark T; Piontek G; Beck C; Boulesteix AL; Scherer EQ; Pigorsch S; Schlegel J; Arnold W; Reiter R
    BMC Cancer; 2011 Sep; 11():388. PubMed ID: 21896192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propranolol as a novel adjunctive treatment for head and neck squamous cell carcinoma.
    Wolter NE; Wolter JK; Enepekides DJ; Irwin MS
    J Otolaryngol Head Neck Surg; 2012 Oct; 41(5):334-44. PubMed ID: 23092836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced proliferation and colony formation of head and neck squamous cell carcinoma (HNSCC) after dual targeting of EGFR and hedgehog pathways.
    Liebig H; Günther G; Kolb M; Mozet C; Boehm A; Dietz A; Wichmann G
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):411-420. PubMed ID: 28110457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.
    Stoehr M; Mozet C; Boehm A; Aigner A; Dietz A; Wichmann G
    Cancer Chemother Pharmacol; 2014 Apr; 73(4):827-37. PubMed ID: 24562588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.
    Wu Y; Palad AJ; Wasilenko WJ; Blackmore PF; Pincus WA; Schechter GL; Spoonster JR; Kohn EC; Somers KD
    Clin Cancer Res; 1997 Nov; 3(11):1915-21. PubMed ID: 9815580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ectopic expression of protein kinase C-β sensitizes head and neck squamous cell carcinoma to diterpene esters.
    Adams RA; D'Souza MM; Pierce CJ; Korica N; Wallwork B; Parsons PG; Panizza B; Boyle GM
    Anticancer Res; 2015 Mar; 35(3):1291-6. PubMed ID: 25750277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion.
    Nyflot MJ; Kruser TJ; Traynor AM; Khuntia D; Yang DT; Hartig GK; McCulloch TM; Wiederholt PA; Gentry LR; Hoang T; Jeraj R; Harari PM
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):942-51. PubMed ID: 25659884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells.
    Guha G; Lu W; Li S; Liang X; Kulesz-Martin MF; Mahmud T; Indra AK; Ganguli-Indra G
    PLoS One; 2015; 10(5):e0125322. PubMed ID: 25938491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 6-shogaol induces apoptosis and enhances radiosensitivity in head and neck squamous cell carcinoma cell lines.
    Kotowski U; Kadletz L; Schneider S; Foki E; Schmid R; Seemann R; Thurnher D; Heiduschka G
    Phytother Res; 2018 Feb; 32(2):340-347. PubMed ID: 29168275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.